It's too complicated to have the trial including people who do not require ventilators. The survival rate is much higher, meaning more participants needed to prove significance, and they would be wasting a lot of good cells on people who were never going to die anyway.
Save the cells for those who actually need them, and go for the conditions with the highest death rate to show as fast as possible and without a hint of doubt, that the treatment works to stop people from dying.
What's the point of dosing people who were never going to die, that's not the point of this treatment, we will not have enough cells to give to everyone, only those who are dying.
- Forums
- ASX - By Stock
- MSB
- clinicaltrials.gov - MSCs in COVID-19 ARDS
clinicaltrials.gov - MSCs in COVID-19 ARDS, page-3
-
- There are more pages in this discussion • 197 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.101B |
Open | High | Low | Value | Volume |
96.5¢ | 99.5¢ | 96.0¢ | $2.283M | 2.340M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29300 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29300 | 0.965 |
12 | 149369 | 0.960 |
4 | 49283 | 0.955 |
8 | 162786 | 0.950 |
3 | 79500 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.970 | 20000 | 1 |
0.975 | 25589 | 3 |
0.980 | 119783 | 8 |
0.985 | 23639 | 4 |
0.990 | 105300 | 7 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |